dapsone has been researched along with Recrudescence in 187 studies
Excerpt | Relevance | Reference |
---|---|---|
"Dapsone is one of the important drugs in the treatment of leprosy." | 9.22 | Risk factors for dapsone resistance in leprosy patients: a systematic meta-analysis. ( Jiang, H; Shi, Y; Wang, C; Wang, H; Wang, Z; Wu, Z, 2022) |
"The cure rates of two treatment regimens in PB leprosy were compared in a prospective randomized trial: treatment U consisting of a single dose of rifampicin 40 mg/K bodyweight, and treatment A of rifampicin 1500 mg in a single dose, followed by one year of daily dapsone 100 mg." | 9.07 | A controlled therapeutic trial in paucibacillary leprosy comparing a single dose of rifampicin with a single dose of rifampicin followed by one year of daily dapsone. The Collaborative Study Group for the Treatment of Leprosy in Zaire. ( Groenen, G; Janssens, L; Kuykens, L; Mputu, LB; Pattyn, SR, 1991) |
"The objective of the present study was to define short-course treatment regimens for PB leprosy and to compare them with the 'classical' dapsone treatment and the WHO-PB regimen." | 9.06 | Evaluation of five treatment regimens, using either dapsone monotherapy or several doses of rifampicin in the treatment of paucibacillary leprosy. ( Baquillon, G; Husser, JA; Jamet, P; Maiga, M; Pattyn, SR, 1990) |
"A clinical trial was initiated at ALERT, Addis Ababa, Ethiopia, to study the effect of one-year supplementary treatment on the incidence of dapsone-resistant leprosy in lepromatous patients already on dapsone monotherapy." | 9.05 | Relapse rate and incidence of dapsone resistance in lepromatous leprosy patients in Addis Ababa: risk factors and effect of short-term supplementary treatment. ( Mengistu, G; Warndorff van Diepen, T, 1985) |
"Patients with borderline-lepromatous (BL) or fully lepromatous (LL) leprosy were treated in the sanitarium for approximately 1 year with oral rifampin (600 mg daily) or with oral dapsone (100 mg daily)." | 9.04 | Rifampin therapy of lepromatous leprosy. ( , 1975) |
"Acedapsone (DADDS), a repository sulfone given by injection five times a year, has been used since 1967 for the treatment of all leprosy patients in the Karimui, an area of diffic-lt access." | 9.04 | Acedapsone (DADDS) treatment of leprosy patients in the Karimui of Papua New Guinea: status at six years. ( McRae, DH; Russell, DA; Scott, GC; Shepard, CC; Vincin, DR, 1975) |
" We report here an unusual case of relapse of toxoplasmic encephalitis in an HIV-infected patient, possibly due to a drug-to-drug interaction between dapsone and minocycline." | 7.75 | Drug-to-drug interaction between dapsone and minocycline: an unusual cause of relapse of toxoplasmic encephalitis in an HIV-infected patient. ( Bigé, N; Gallien, S; Gervais, A; Kitzis, MD; Leport, C; Longuet, P, 2009) |
"794 MB leprosy patients who had been released from treatment after dapsone monotherapy were selected, amongst them 657 were re-treated for 1 year using the modified multidrug therapy regimen (mMDT) including rifampicin, clofazimine and dapsone, and 137 patients were observed as control cases." | 7.75 | Twenty five years follow up of MB leprosy patients retreated with a modified MDT regimen after a full course of dapsone mono-therapy. ( Chen, J; Jing, Z; Zhang, R; Zhou, D, 2009) |
"To detect the presence of rifampin- and dapsone-resistant strains of Mycobacterium leprae in three patients with recurring leprosy and clinically-suspected antimicrobial resistance through molecular techniques." | 7.74 | [Study of rifampin and dapsone resistance in three patients with recurring leprosy]. ( Beltrán, C; Cardona-Castro, N; Gómez, Y; Hernández, E; Kimura, M; Rodríguez, G; Villegas, S; Vissa, VD, 2008) |
"Dapsone has been used successfully as adjuvant therapy for bullous pemphigoid (BP)." | 7.73 | Treatment of bullous pemphigoid with dapsone, methylprednisolone, and topical clobetasol propionate: a retrospective study of 62 cases. ( Bröcker, EB; Goebeler, M; Kraensel, R; Rzany, B; Schmidt, E; Sinkgraven, R; Zillikens, D, 2005) |
"Based upon the data from the Chinese National System for Leprosy Surveillance, this paper reports on the relapses in 297,343 leprosy patients [multibacillary (MB) 106,518, paucibacillary (PB) 190,825] cured by dapsone monotherapy." | 7.70 | Studies on risk of leprosy relapses in China: relapses after treatment with dapsone monotherapy. ( Chen, XS; Jiang, C; Li, WZ; Ye, GY, 1999) |
"We report the first case of eosinophilic pustular folliculitis (Ofuji's disease) which was successfully treated with acitretin." | 7.69 | [Ofuji's eosinophilic pustular folliculitis. Efficacy of acitretin]. ( Bergoend, H; Catteau, B; Delaporte, E; Dubost-Brama, A; Piette, F; Warembourg, A, 1997) |
"Before implementation of multidrug therapy (MDT), leprosy patients who were clinically inactive, skin-smear negative and had been treated with dapsone monotherapy for at least 5 years (paucibacillary patients) or for at least 10 years (multibacillary patients) were released from treatment." | 7.68 | Relapses in leprosy patients after release from dapsone monotherapy; experience in the leprosy control program of the all Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia. ( Becx-Bleumink, M, 1992) |
"In an open study, a total of 18 patients with proven bullous pemphigoid (16 new patients and two in relapse) were treated with a trial of dapsone (17 patients) or sulphonimide (one patient)." | 7.67 | Dapsone as first line therapy for bullous pemphigoid. ( Millard, PR; Venning, VA; Wojnarowska, F, 1989) |
"This is a report on two cases with pemphigus vulgaris effectively controlled by dapsone." | 7.66 | Dapsone in the treatment of pemphigus vulgaris. ( Friedman-Birnbaum, R; Haim, S, 1978) |
"The 1,659 non-leprous people in a Micronesian population experiencing an annual leprosy incidence rate of about 7/1,000 were offered 15 acedapsone (DADDS) injections during 1967--1970 for leprosy prevention purposes." | 7.66 | Acedapsone in the prevention of leprosy: field trial in three high prevalence villages in Micronesia. ( Fasal, P; Jano, B; Russell, DA; Shepard, CC; Worth, RM, 1979) |
"This paper summarises our clinical experience with clofazimine in the treatment of 25 cases of reactive states of lepromatous and borderline leprosy and 7 lepromatous patients not responding to dapsone." | 7.65 | Clinical trial with clofazimine in leprosy. ( Dongre, VV; Ganapati, R, 1976) |
" Studies included were trials in which: (1) the participants were classified as having GCA by the 1990 ACR criteria or biopsy proven disease; (2) parallel-group randomised control of at least 16 weeks duration had been conducted with at least 20 participants; (3) the design included either alternative adjunct immunosuppressant regimens, alternative GCs dosing or routes of administration; and (4) outcome data was included on either relapse rates or rates of infection." | 6.50 | Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis. ( Loke, YK; MacGregor, AJ; Watts, RA; Yates, M, 2014) |
"We describe a 46-year-old man with Hodgkin's disease in whom neutrophilic eccrine hidradenitis developed after each of the first two treatments with lomustine." | 6.39 | Dapsone in prevention of recurrent neutrophilic eccrine hidradenitis. ( Knowles, SR; Poldre, P; Shapiro, L; Shear, NH, 1996) |
"Dapsone is a chemotherapeutic agent with anti-inflammatory properties that is used as a steroid-sparing agent in PV." | 5.43 | Efficacy of Dapsone in the Treatment of Pemphigus Vulgaris: A Single-Center Case Study. ( Barzilai, A; Baum, S; Debby, A; Gilboa, S; Trau, H, 2016) |
"IgA pemphigus is a particular entity among autoimmune blistering intraepidermal diseases." | 5.39 | [Efficacy of acitretin in IgA pemphigus]. ( Bellissen, A; Gosset, P; Lasek, A; Lebas, D; Modiano, P; Wantz, M, 2013) |
"Rapid recurrence after stopping treatment however suggests that anti-inflammatory effects may predominate." | 5.37 | Dapsone therapy for hidradenitis suppurativa: a series of 24 patients. ( Boer, J; Ingvarsson, G; Jemec, GB; Szepietowski, JC; Yazdanyar, S, 2011) |
"Dapsone is one of the important drugs in the treatment of leprosy." | 5.22 | Risk factors for dapsone resistance in leprosy patients: a systematic meta-analysis. ( Jiang, H; Shi, Y; Wang, C; Wang, H; Wang, Z; Wu, Z, 2022) |
"The cure rates of two treatment regimens in PB leprosy were compared in a prospective randomized trial: treatment U consisting of a single dose of rifampicin 40 mg/K bodyweight, and treatment A of rifampicin 1500 mg in a single dose, followed by one year of daily dapsone 100 mg." | 5.07 | A controlled therapeutic trial in paucibacillary leprosy comparing a single dose of rifampicin with a single dose of rifampicin followed by one year of daily dapsone. The Collaborative Study Group for the Treatment of Leprosy in Zaire. ( Groenen, G; Janssens, L; Kuykens, L; Mputu, LB; Pattyn, SR, 1991) |
"The objective of the present study was to define short-course treatment regimens for PB leprosy and to compare them with the 'classical' dapsone treatment and the WHO-PB regimen." | 5.06 | Evaluation of five treatment regimens, using either dapsone monotherapy or several doses of rifampicin in the treatment of paucibacillary leprosy. ( Baquillon, G; Husser, JA; Jamet, P; Maiga, M; Pattyn, SR, 1990) |
"A clinical trial was initiated at ALERT, Addis Ababa, Ethiopia, to study the effect of one-year supplementary treatment on the incidence of dapsone-resistant leprosy in lepromatous patients already on dapsone monotherapy." | 5.05 | Relapse rate and incidence of dapsone resistance in lepromatous leprosy patients in Addis Ababa: risk factors and effect of short-term supplementary treatment. ( Mengistu, G; Warndorff van Diepen, T, 1985) |
"Patients with borderline-lepromatous (BL) or fully lepromatous (LL) leprosy were treated in the sanitarium for approximately 1 year with oral rifampin (600 mg daily) or with oral dapsone (100 mg daily)." | 5.04 | Rifampin therapy of lepromatous leprosy. ( , 1975) |
"Acedapsone (DADDS), a repository sulfone given by injection five times a year, has been used since 1967 for the treatment of all leprosy patients in the Karimui, an area of diffic-lt access." | 5.04 | Acedapsone (DADDS) treatment of leprosy patients in the Karimui of Papua New Guinea: status at six years. ( McRae, DH; Russell, DA; Scott, GC; Shepard, CC; Vincin, DR, 1975) |
"From 2009 to 2015, multi-bacillary leprosy cases at sentinel sites of 19 countries were studied for resistance to rifampicin, dapsone and ofloxacin by PCR sequencing of the drug-resistance-determining regions of the genes rpoB, folP1 and gyrA." | 3.88 | Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009-15. ( Cambau, E; Cardona-Castro, N; Cauchoix, B; Cole, ST; Cooreman, EAWD; Gillini, L; Gupta, UD; Hagge, D; Hongseng, W; Indropo, A; Johnson, RC; Kai, M; Lavania, M; Matsuoka, M; Miyamoto, Y; Pannikar, VK; Pemmaraju, VRR; Rosa, PS; Saunderson, P; Srikantam, A; Suffys, P; Vissa, V; Williams, D, 2018) |
" Histological analysis of one of these nodules resulted in diagnosis of chronic erythema elevatum diutinum and treatment with dapsone was initiated." | 3.76 | [Erythema elevatum diutinum associated with pyoderma gangrenosum in an HIV-positive patient]. ( Andre, C; Bagot, M; Duriez, P; Lascaux-Cametz, AS; Maksimovic, L; Ortonne, N; Revuz, J, 2010) |
"794 MB leprosy patients who had been released from treatment after dapsone monotherapy were selected, amongst them 657 were re-treated for 1 year using the modified multidrug therapy regimen (mMDT) including rifampicin, clofazimine and dapsone, and 137 patients were observed as control cases." | 3.75 | Twenty five years follow up of MB leprosy patients retreated with a modified MDT regimen after a full course of dapsone mono-therapy. ( Chen, J; Jing, Z; Zhang, R; Zhou, D, 2009) |
" We report here an unusual case of relapse of toxoplasmic encephalitis in an HIV-infected patient, possibly due to a drug-to-drug interaction between dapsone and minocycline." | 3.75 | Drug-to-drug interaction between dapsone and minocycline: an unusual cause of relapse of toxoplasmic encephalitis in an HIV-infected patient. ( Bigé, N; Gallien, S; Gervais, A; Kitzis, MD; Leport, C; Longuet, P, 2009) |
"To investigate the effectiveness of colchicine and dapsone, 2 corticosteroid-sparing anti-inflammatory agents, in the treatment of patients with complex aphthosis (recurrent oral and genital aphthous ulcers or severe, almost constant, multiple oral aphthae in the absence of Behçet syndrome)." | 3.75 | Successful treatment of complex aphthosis with colchicine and dapsone. ( Bruce, AJ; Lynde, CB; Rogers, RS, 2009) |
"To detect the presence of rifampin- and dapsone-resistant strains of Mycobacterium leprae in three patients with recurring leprosy and clinically-suspected antimicrobial resistance through molecular techniques." | 3.74 | [Study of rifampin and dapsone resistance in three patients with recurring leprosy]. ( Beltrán, C; Cardona-Castro, N; Gómez, Y; Hernández, E; Kimura, M; Rodríguez, G; Villegas, S; Vissa, VD, 2008) |
"Dapsone has been used successfully as adjuvant therapy for bullous pemphigoid (BP)." | 3.73 | Treatment of bullous pemphigoid with dapsone, methylprednisolone, and topical clobetasol propionate: a retrospective study of 62 cases. ( Bröcker, EB; Goebeler, M; Kraensel, R; Rzany, B; Schmidt, E; Sinkgraven, R; Zillikens, D, 2005) |
" The disease can be discriminated from prurigo simplex subacuta by the typical reticular hyperpigmentation, by the sparing of arms and legs and by the response to treatment with dapsone or minocycline." | 3.71 | [Prurigo pigmentosa]. ( Aramaki, J; Happle, R, 2001) |
"Based upon the data from the Chinese National System for Leprosy Surveillance, this paper reports on the relapses in 297,343 leprosy patients [multibacillary (MB) 106,518, paucibacillary (PB) 190,825] cured by dapsone monotherapy." | 3.70 | Studies on risk of leprosy relapses in China: relapses after treatment with dapsone monotherapy. ( Chen, XS; Jiang, C; Li, WZ; Ye, GY, 1999) |
"There are many case reports of dapsone overdose in adults but only a few reports of dapsone-induced methemoglobinemia in children." | 3.69 | Acute dapsone intoxication: a pediatric case report. ( MacDonald, RD; McGuigan, MA, 1997) |
"We report the first case of eosinophilic pustular folliculitis (Ofuji's disease) which was successfully treated with acitretin." | 3.69 | [Ofuji's eosinophilic pustular folliculitis. Efficacy of acitretin]. ( Bergoend, H; Catteau, B; Delaporte, E; Dubost-Brama, A; Piette, F; Warembourg, A, 1997) |
"Many leprosy patients treated with multidrug therapy (MDT) had previously received dapsone (DDS) monotherapy for many years." | 3.69 | Relapse with multibacillary leprosy caused by rifampicin sensitive organisms following paucibacillary multidrug therapy. ( Britton, WJ; Neupane, K; Soares, DJ, 1995) |
"The proportion of relapses among all patients detected each year increased steadily since the initiation of the national leprosy control program in China with dapsone monotherapy in 1955, reaching 18%-24% in the more leprosy-endemic provinces along the coast." | 3.68 | Problems of leprosy relapse in China. ( Li, HY, 1993) |
"We analyzed the records of 1022 patients of paucibacillary leprosy who had received either 6 doses of WHO-MDT alone (" classical" MDT, 668 patients) or had post-MDT dapsone for at least 6 months ("modified" MDT, 354 patients)." | 3.68 | Fixed duration MDT in paucibacillary leprosy (classical and modified). ( Grugni, A; Kini, MS; Nadkarni, NJ, 1993) |
"Before implementation of multidrug therapy (MDT), leprosy patients who were clinically inactive, skin-smear negative and had been treated with dapsone monotherapy for at least 5 years (paucibacillary patients) or for at least 10 years (multibacillary patients) were released from treatment." | 3.68 | Relapses in leprosy patients after release from dapsone monotherapy; experience in the leprosy control program of the all Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia. ( Becx-Bleumink, M, 1992) |
"In an open study, a total of 18 patients with proven bullous pemphigoid (16 new patients and two in relapse) were treated with a trial of dapsone (17 patients) or sulphonimide (one patient)." | 3.67 | Dapsone as first line therapy for bullous pemphigoid. ( Millard, PR; Venning, VA; Wojnarowska, F, 1989) |
"Three multidrug regimens all containing rifampin and dapsone have been tried for the treatment of 278 cases of paucibacillary leprosy." | 3.67 | Relapses in paucibacillary patients after treatment with three short-term regimens containing rifampin. ( Bagga, AK; Bhatia, AS; Katoch, K; Natrajan, M; Ramanathan, U; Ramu, G; Saxena, RK, 1989) |
"Oral zinc sulfate was tried in Eight cases of recurrent Erythema Nodosum Leprosum." | 3.66 | Oral zinc in recurrent Erythema Nodosum Leprosum reaction. ( Bumb, RA; Mangal, HN; Mathur, NK, 1983) |
"The 1,659 non-leprous people in a Micronesian population experiencing an annual leprosy incidence rate of about 7/1,000 were offered 15 acedapsone (DADDS) injections during 1967--1970 for leprosy prevention purposes." | 3.66 | Acedapsone in the prevention of leprosy: field trial in three high prevalence villages in Micronesia. ( Fasal, P; Jano, B; Russell, DA; Shepard, CC; Worth, RM, 1979) |
"This is a report on two cases with pemphigus vulgaris effectively controlled by dapsone." | 3.66 | Dapsone in the treatment of pemphigus vulgaris. ( Friedman-Birnbaum, R; Haim, S, 1978) |
" Reactive episodes continue to be a serious complication, but the availability of thalidomide to control erythema nodosum leprosum has markedly improved the prognosis." | 3.65 | The diagnosis and treatment of leprosy. ( Jacobson, RR; Trautman, JR, 1976) |
"This paper summarises our clinical experience with clofazimine in the treatment of 25 cases of reactive states of lepromatous and borderline leprosy and 7 lepromatous patients not responding to dapsone." | 3.65 | Clinical trial with clofazimine in leprosy. ( Dongre, VV; Ganapati, R, 1976) |
"Dapsone is an antibacterial sulfonamide with anti-inflammatory property, which showed therapeutic activity in patients with immune thrombocytopenia (ITP); the activity in patients who showed refractoriness to rituximab is unknown." | 2.77 | Dapsone salvage therapy for adult patients with immune thrombocytopenia relapsed or refractory to steroid and rituximab. ( Chiozzotto, M; Fanin, R; Marin, L; Puglisi, S; Volpetti, S; Zaja, F, 2012) |
"Colchicine was administered to a total of ten patients, with benefits observed in nine (90%), of whom four showed complete remission." | 2.74 | Systemic treatment in severe cases of recurrent aphthous stomatitis: an open trial. ( Hirota, SK; Migliari, DA; Mimura, MA; Sanches, JA; Sugaya, NN, 2009) |
"No confirmed relapse has been observed within a follow-up period of 6 months to 7 years and 3 months [59 person-years at risk (PYR)] for TT/BT patients and of 4 months to 5 years and 10 months (100 PYR) for BB/BL/LL patients." | 2.68 | Daily multidrug therapy for leprosy; results of a fourteen-year experience. ( Cottenot, F; de Carsalade, GY; Flageul, B; Pennec, J; Spindler, E; Wallach, D, 1997) |
"No further relapse has been diagnosed since the beginning of retreatment." | 2.68 | High relapse rate among lepromatous leprosy patients treated with rifampin plus ofloxacin daily for 4 weeks. ( Grosset, JH; Jamet, P; Ji, B; Perani, EG; Sow, S; Traore, I, 1997) |
"Rhinosporidiosis is a fairly common problem for the Otolaryngologist in many parts of the world, because of its prompt recurrence after surgical excision." | 2.65 | Clinical trial of diaminodiphenylsulfone (DDS) in nasal and nasopharyngeal rhinosporidiosis. ( Nair, KK, 1979) |
"Pemphigus is a group of autoimmune intraepidermal bullous diseases; being pemphigus foliaceus (PF) and pemphigus vulgaris (PV) the most common subtypes." | 2.53 | Pemphigus foliaceus with circinated plaques and neutrophil pustules. ( Avalos-Diaz, E; Dominguez-Cherit, J; Esquivel-Pedraza, L; Méndez-Flores, S; Saeb-Lima, M, 2016) |
" Studies included were trials in which: (1) the participants were classified as having GCA by the 1990 ACR criteria or biopsy proven disease; (2) parallel-group randomised control of at least 16 weeks duration had been conducted with at least 20 participants; (3) the design included either alternative adjunct immunosuppressant regimens, alternative GCs dosing or routes of administration; and (4) outcome data was included on either relapse rates or rates of infection." | 2.50 | Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis. ( Loke, YK; MacGregor, AJ; Watts, RA; Yates, M, 2014) |
"Giant cell arteritis is a medium- and large-vessel vasculitis, the most prevalent systemic vasculitis in subjects over age 60." | 2.44 | [Giant cell arteritis]. ( Liozon, E; Ly, K, 2008) |
"We describe a 46-year-old man with Hodgkin's disease in whom neutrophilic eccrine hidradenitis developed after each of the first two treatments with lomustine." | 2.39 | Dapsone in prevention of recurrent neutrophilic eccrine hidradenitis. ( Knowles, SR; Poldre, P; Shapiro, L; Shear, NH, 1996) |
"This is the first reported case of rhinosporidiosis in Ibadan, Nigeria." | 2.39 | Rhinosporodium: case report. ( Adeyemi, FA; Aghadiuno, PU; Akang, EE; Ashiru, JO; Ijaduola, GT, 1996) |
"Relapses are an indicator of MDT effectiveness and can reflect Mycobacterium leprae persistence or re-infection." | 1.62 | Low rate of relapse after twelve-dose multidrug therapy for hansen's disease: A 20-year cohort study in a brazilian reference center. ( Hacker, MAVB; Illarramendi, X; Maia, RC; Moraes, MO; Nery, JAC; Sales, AM; Sarno, EN, 2021) |
"Dapsone is a chemotherapeutic agent with anti-inflammatory properties that is used as a steroid-sparing agent in PV." | 1.43 | Efficacy of Dapsone in the Treatment of Pemphigus Vulgaris: A Single-Center Case Study. ( Barzilai, A; Baum, S; Debby, A; Gilboa, S; Trau, H, 2016) |
"IgA pemphigus is a particular entity among autoimmune blistering intraepidermal diseases." | 1.39 | [Efficacy of acitretin in IgA pemphigus]. ( Bellissen, A; Gosset, P; Lasek, A; Lebas, D; Modiano, P; Wantz, M, 2013) |
"Patients with Behcet's disease without oral ulcers and other diagnoses such as pemphigus vulgaris, lichen planus and herpes simplex were excluded." | 1.38 | Oral aphthosis: management gaps and recent advances. ( Liang, MW; Neoh, CY, 2012) |
"Rhinosporidiosis is a non-contagious chronic granulomatous disease that is prevalent in southern India and Sri Lanka." | 1.38 | Rhinosporidiosis in southwest Bengal. ( Biswas, BK; Chowdhury, MK; Majhi, TK; Mallick, AA; Pal, DK, 2012) |
"Rapid recurrence after stopping treatment however suggests that anti-inflammatory effects may predominate." | 1.37 | Dapsone therapy for hidradenitis suppurativa: a series of 24 patients. ( Boer, J; Ingvarsson, G; Jemec, GB; Szepietowski, JC; Yazdanyar, S, 2011) |
"Cutaneous periarteritis nodosa was diagnosed on histological findings and absence of extracutaneous manifestations." | 1.33 | [Reversible lower limb lymphedema as the first manifestation of cutaneous periarteritis nodosa]. ( Haicault de la Regontais, G; Hanslik, T; Stoyanova, M; Vasseur, E; Vignes, S, 2005) |
"Eleven of these had a recrudescence of their infection." | 1.33 | Artesunate-dapsone-proguanil treatment of falciparum malaria: genotypic determinants of therapeutic response. ( Imwong, M; Krudsood, S; Looareesuwan, S; Nonprasert, A; Pukrittayakamee, S; Snounou, G; White, NJ; Wilairatana, P, 2005) |
"Leprosy is well controlled in Hong Kong but continued surveillance is required to detect relapses and to ensure good patient compliance with treatment." | 1.33 | Epidemiology of leprosy and response to treatment in Hong Kong. ( Ho, CK; Lo, KK, 2006) |
"Rhinosporidiosis is a chronic granulomatous disease that commonly affects the nasal and nasopharyngeal mucosa." | 1.33 | Disseminated rhinosporidiosis - an unusual presentation with pulmonary involvement. ( Jagdish, S; Pai, D; Rajakannu, M; Sri Vengadesh, G, 2006) |
"We report two cases of Hansen's disease." | 1.32 | [Two cases of Hansen's disease]. ( Horii, N; Ichikawa, E; Ishii, N; Koseki, M; Otsuka, F; Sugita, Y; Tanaka, M, 2003) |
"Areas of low endemicity of Hansen's disease, such as Texas, California, and Hawaii, exist due to immigration and rare autochthonous infections." | 1.32 | Short report: Treatment failure in Hansen's disease. ( Joyce, MP; Longfield, RN; Murray, CK, 2003) |
"Skin biopsy supported diagnosis of polyarteritis nodosa." | 1.31 | [Cutaneous polyarteritis nodosa in children: three cases]. ( Assicot, C; Bourrat, E; Moraillon, I; Prigent, F; Rybojad, M; Triller, R; Vignon, MD, 2002) |
"Treatment with dapsone may be beneficial." | 1.30 | Pterygium with granuloma faciale-like histologic picture. ( Havelius, U; Rausing, A, 1998) |
"Cyclic neutropenia is a rare hematologic disorder of unknown origin." | 1.30 | [Recurrent episodes of ulcerative gingivostomatitis associated with cyclic neutropenia]. ( Djawari, J; Sucker, C, 1999) |
" Therefore dapsone therapy was initiated at a dosage of 100 mg daily after checking the glucose-6-phosphate-dehydrogenase and with regular control of the blood methemoglobin level." | 1.30 | [Henoch-Schönlein purpura: successful treatment with Dapsone]. ( Abeck, D; Albrecht, J; Hein, R; Mempel, M; Ring, J, 1999) |
"Recurrent erythema multiforme is an uncommon disorder." | 1.29 | Recurrent erythema multiforme: clinical features and treatment in a large series of patients. ( Leigh, IM; Schofield, JK; Tatnall, FM, 1993) |
"One patient had a recurrence of PCP at 4 mo, after a negative 1-mo BAL." | 1.29 | Persistence of Pneumocystis carinii in patients with AIDS receiving chemoprophylaxis. ( Antonson, S; Epstein, LJ; Meyer, RD; Mohsenifar, Z; Strigle, SM, 1994) |
"Occurrence or recurrence of PCP." | 1.29 | Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study. ( Hoover, DR; Kingsley, LA; Peng, Y; Phair, JP; Saah, AJ; Schrager, LK; Visscher, B, 1995) |
"The prevention of the occurrence and recurrence of PCP is a cornerstone in the treatment of patients infected with the human immunodeficiency virus." | 1.28 | A comparison of the effectiveness of three regimens in the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients. ( Beall, GN; Beck, K; Cox, PH; Martin, MA; Styer, CM, 1992) |
"Bullous pemphigoid is a clinically heterogeneous disease although little is known of the factors affecting its course and outcome." | 1.28 | Lack of predictive factors for the clinical course of bullous pemphigoid. ( Venning, VA; Wojnarowska, F, 1992) |
"Dapsone was tried in one case with apparent benefit." | 1.28 | Eosinophilic pustulosis of the scalp in childhood. ( Bassan-Andrieu, L; Maleville, J; Taïeb, A, 1992) |
"Ocular cicatricial pemphigoid (OCP) is a chronic, progressive, autoimmune disease that scars mucus membranes and may lead to blindness." | 1.28 | Remission and recurrence after withdrawal of therapy for ocular cicatricial pemphigoid. ( Foster, CS; Neumann, R; Tauber, J, 1991) |
"In 33 consecutive AIDS patients with a first episode of Pneumocystis carinii pneumonia (PCP) we evaluated treatment, outcome, recurrence rate and pyrimethamine as chemoprophylaxis in a 1-year follow-up." | 1.28 | Pneumocystis carinii pneumonia in Stockholm, Sweden: treatment, outcome, one-year-follow-up and pyrimethamine prophylaxis. ( Bergdahl, S; Julander, I; Lidman, C; Lundbergh, P; Ortqvist, A, 1989) |
"Dapsone has been used since 1976 in the treatment of relapsing polychondritis." | 1.27 | [Chronic atrophic polychondritis. Critical analysis of the therapeutic efficacy of dapsone. 2 cases]. ( Abadie, JC; Gouet, D; Marechaud, R; Neau, JP; Rossi, F; Sudre, Y, 1984) |
" Nineteen patients had ocular manifestations of giant cell arteritis always from the onset, except for a fall in visual acuity; 26 relapses were observed in 18 patients, either during reduction of steroid dosage (21 cases) or after withdrawal (5 cases)." | 1.27 | [Prognosis of treated temporal arteritis. Retrospective study of 87 cases]. ( Alcalay, M; Becq-Giraudon, B; Boissonnot, L; Bontoux, D; Gil, R; Gouet, D; Le Berre, D; Lefevre, JP; Maréchaud, R; Risse, JF, 1986) |
""Relapse" was defined as the reappearance of Mycobacterium leprae in skin smears." | 1.27 | Relapse rates in lepromatous leprosy according to treatment regularity. ( Almeida, JG; Chacko, CJ; Christian, M; Jesudasan, K, 1986) |
"Dermatitis herpetiformis was diagnosed in seventy-six children by its clinical features and by detection of granular IgA deposits in the papillary dermis of perilesional skin." | 1.27 | Long-term follow-up of dermatitis herpetiformis in children. ( Cucchi, G; Ermacora, E; Gelmetti, C; Gianotti, F; Giunta, A; Pezzoli, G; Prampolini, L; Tettamanti, A; Tribbia, G, 1986) |
" The initial dosage of either of the drugs was 300 mg daily administered in divided doses of 100 mg three times a day." | 1.26 | Treatment of steroid dependant cases of recurrent lepra reaction with a combination of thalidomide and clofazimine. ( Girdhar, A; Ramu, G, 1979) |
" Low dosage favoured the appearance of resistance; therefore regular treatment of lepromatous leprosy with dapsone in full dosage is recommended." | 1.25 | Sulphone resistance in leprosy. A review of one hundred proven clinical cases. ( Pearson, JM; Rees, RJ; Waters, MF, 1975) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 63 (33.69) | 18.7374 |
1990's | 52 (27.81) | 18.2507 |
2000's | 37 (19.79) | 29.6817 |
2010's | 31 (16.58) | 24.3611 |
2020's | 4 (2.14) | 2.80 |
Authors | Studies |
---|---|
Andrade, ESN | 1 |
Brandão, JG | 1 |
Silva, JSD | 1 |
Coriolano, CRF | 1 |
Rosa, PS | 3 |
Moraes, MO | 2 |
Ferreira, CO | 1 |
Gomes, CM | 1 |
Araújo, WN | 1 |
Wu, Z | 1 |
Wang, C | 1 |
Wang, Z | 1 |
Shi, Y | 1 |
Jiang, H | 1 |
Wang, H | 1 |
Davies, OMT | 1 |
Hill, IM | 1 |
Chiu, YE | 1 |
Tagka, A | 1 |
Lambrou, GI | 1 |
Nicolaidou, E | 1 |
Nakou, E | 1 |
Makris, M | 1 |
Stratigos, A | 1 |
Katsarou, A | 1 |
Nery, JAC | 1 |
Sales, AM | 1 |
Hacker, MAVB | 1 |
Maia, RC | 1 |
Sarno, EN | 1 |
Illarramendi, X | 1 |
Penna, GO | 1 |
Bührer-Sékula, S | 1 |
Kerr, LRS | 1 |
Stefani, MMA | 1 |
Rodrigues, LC | 1 |
de Araújo, MG | 1 |
Ramos, AMC | 1 |
de Andrade, ARC | 1 |
Costa, MB | 1 |
Gonçalves, HS | 1 |
Cruz, R | 1 |
Barreto, ML | 1 |
Pontes, MAA | 1 |
Penna, MLF | 1 |
Shah, PM | 1 |
Dhakre, VW | 1 |
Prasad, A | 1 |
Samdani, P | 1 |
Cambau, E | 2 |
Saunderson, P | 2 |
Matsuoka, M | 1 |
Cole, ST | 2 |
Kai, M | 1 |
Suffys, P | 1 |
Williams, D | 1 |
Gupta, UD | 1 |
Lavania, M | 1 |
Cardona-Castro, N | 3 |
Miyamoto, Y | 1 |
Hagge, D | 1 |
Srikantam, A | 1 |
Hongseng, W | 1 |
Indropo, A | 1 |
Vissa, V | 1 |
Johnson, RC | 1 |
Cauchoix, B | 1 |
Pannikar, VK | 1 |
Cooreman, EAWD | 1 |
Pemmaraju, VRR | 1 |
Gillini, L | 1 |
Tavares Rodrigues, F | 1 |
Pereira Cardozo, MR | 1 |
da Costa Nery, JA | 1 |
Drerup, C | 1 |
Hake, L | 1 |
Oji, V | 1 |
Sunderkötter, C | 1 |
Hiraga, A | 1 |
Ozaki, D | 1 |
Oikawa, M | 1 |
Araki, N | 1 |
Kuwabara, S | 1 |
Yates, M | 1 |
Loke, YK | 1 |
Watts, RA | 1 |
MacGregor, AJ | 1 |
Bellissen, A | 1 |
Lebas, D | 1 |
Wantz, M | 1 |
Gosset, P | 1 |
Lasek, A | 1 |
Modiano, P | 1 |
Koketsu, H | 1 |
Ricotti, C | 1 |
Kerdel, FA | 1 |
Mael-Ainin, M | 1 |
Senouci, K | 1 |
Rotondo, C | 1 |
Lopalco, G | 1 |
Iannone, F | 1 |
Vitale, A | 1 |
Talarico, R | 1 |
Galeazzi, M | 1 |
Lapadula, G | 1 |
Cantarini, L | 1 |
Kitamura, S | 1 |
Hamauchi, A | 1 |
Ota, M | 1 |
Watts, PJ | 1 |
Khachemoune, A | 1 |
Méndez-Flores, S | 1 |
Avalos-Diaz, E | 1 |
Dominguez-Cherit, J | 1 |
Saeb-Lima, M | 1 |
Esquivel-Pedraza, L | 1 |
Baum, S | 1 |
Debby, A | 1 |
Gilboa, S | 1 |
Trau, H | 1 |
Barzilai, A | 1 |
Beltrán-Alzate, C | 1 |
López Díaz, F | 1 |
Romero-Montoya, M | 1 |
Sakamuri, R | 1 |
Li, W | 1 |
Kimura, M | 2 |
Brennan, P | 1 |
Oak, AS | 1 |
Seminario-Vidal, L | 1 |
Sami, N | 1 |
Liozon, E | 2 |
Ly, K | 1 |
Chakma, JK | 1 |
Girdhar, A | 3 |
Natrajan, M | 3 |
Kumar, A | 1 |
Girdhar, BK | 2 |
Owen, CE | 1 |
Malone, JC | 1 |
Callen, JP | 1 |
Lynde, CB | 1 |
Bruce, AJ | 1 |
Rogers, RS | 1 |
Mimura, MA | 1 |
Hirota, SK | 1 |
Sugaya, NN | 1 |
Sanches, JA | 1 |
Migliari, DA | 1 |
Gallien, S | 1 |
Bigé, N | 1 |
Kitzis, MD | 1 |
Longuet, P | 1 |
Gervais, A | 1 |
Leport, C | 1 |
Jing, Z | 1 |
Zhang, R | 1 |
Zhou, D | 1 |
Chen, J | 1 |
Veien, NK | 1 |
Moulis, G | 1 |
Bagheri, H | 1 |
Saint Martory, J | 1 |
Bernard, P | 2 |
Montastruc, JL | 1 |
Maksimovic, L | 1 |
Duriez, P | 1 |
Lascaux-Cametz, AS | 1 |
Andre, C | 1 |
Bagot, M | 1 |
Revuz, J | 1 |
Ortonne, N | 1 |
Balagon, MF | 1 |
Cellona, RV | 1 |
Abalos, RM | 1 |
Gelber, RH | 1 |
Saunderson, PR | 1 |
Lekhanont, K | 1 |
Patarakittam, T | 1 |
Mantachote, K | 1 |
Waiyawatjamai, P | 1 |
Vongthongsri, A | 1 |
Charneux, J | 1 |
Maghanoy, A | 1 |
Mallari, I | 1 |
Balagon, M | 1 |
Yazdanyar, S | 1 |
Boer, J | 1 |
Ingvarsson, G | 1 |
Szepietowski, JC | 1 |
Jemec, GB | 1 |
Zaja, F | 1 |
Marin, L | 1 |
Chiozzotto, M | 1 |
Puglisi, S | 1 |
Volpetti, S | 1 |
Fanin, R | 1 |
Mori, S | 1 |
Yotsu, RR | 1 |
Suzuki, K | 1 |
Makino, M | 1 |
Ishii, N | 2 |
Pal, DK | 1 |
Mallick, AA | 1 |
Majhi, TK | 1 |
Biswas, BK | 1 |
Chowdhury, MK | 1 |
Durant, C | 1 |
Hadj-Khelifa, S | 1 |
Lei, J | 1 |
Badaoui, A | 1 |
Moreau, AS | 1 |
Traineau, R | 1 |
Farge, D | 1 |
Decaux, O | 1 |
Liang, MW | 1 |
Neoh, CY | 1 |
Sulo, J | 1 |
Chimpeni, P | 1 |
Hatcher, J | 1 |
Kublin, JG | 1 |
Plowe, CV | 1 |
Molyneux, ME | 1 |
Marsh, K | 1 |
Taylor, TE | 1 |
Watkins, WM | 1 |
Winstanley, PA | 1 |
Aviña-Zubieta, JA | 1 |
Galindo-Rodrìguez, G | 1 |
Robledo, I | 1 |
Vela-Ojeda, J | 1 |
Vadillo-Buenfil, M | 1 |
Rosas-Cabral, A | 1 |
Salazar-Exaire, D | 1 |
Murray, CK | 1 |
Joyce, MP | 1 |
Longfield, RN | 1 |
Ichikawa, E | 1 |
Otsuka, F | 1 |
Horii, N | 1 |
Tanaka, M | 1 |
Sugita, Y | 1 |
Koseki, M | 1 |
Bardella, MT | 1 |
Fredella, C | 1 |
Trovato, C | 1 |
Ermacora, E | 2 |
Cavalli, R | 1 |
Saladino, V | 1 |
Prampolini, L | 2 |
Norman, G | 1 |
Joseph, G | 1 |
Richard, J | 1 |
Lu, CI | 1 |
Yang, CH | 1 |
Hong, HS | 1 |
Abramovits, W | 1 |
Stevenson, LC | 1 |
Krudsood, S | 1 |
Imwong, M | 1 |
Wilairatana, P | 1 |
Pukrittayakamee, S | 1 |
Nonprasert, A | 1 |
Snounou, G | 1 |
White, NJ | 1 |
Looareesuwan, S | 1 |
Vignes, S | 1 |
Stoyanova, M | 1 |
Vasseur, E | 1 |
Haicault de la Regontais, G | 1 |
Hanslik, T | 1 |
Armour, KS | 1 |
Scolyer, RA | 1 |
Barnetson, RS | 1 |
Shen, JP | 1 |
Gupte, MD | 1 |
Jiang, C | 2 |
Manickam, P | 1 |
Yu, MW | 1 |
Li, WZ | 2 |
Schmidt, E | 1 |
Kraensel, R | 1 |
Goebeler, M | 1 |
Sinkgraven, R | 1 |
Bröcker, EB | 1 |
Rzany, B | 1 |
Zillikens, D | 2 |
Rose, C | 1 |
Carthagena, L | 1 |
Chauffour, A | 1 |
Ji, B | 2 |
Jarlier, V | 1 |
Rajakannu, M | 1 |
Sri Vengadesh, G | 1 |
Pai, D | 1 |
Jagdish, S | 1 |
Hoffman, LD | 1 |
Hoffman, MD | 1 |
Ho, CK | 1 |
Lo, KK | 1 |
Fukae, J | 1 |
Noda, K | 1 |
Fujishima, K | 1 |
Wada, R | 1 |
Yoshiike, T | 1 |
Hattori, N | 1 |
Okuma, Y | 1 |
Hernández, E | 1 |
Rodríguez, G | 1 |
Villegas, S | 1 |
Beltrán, C | 1 |
Vissa, VD | 1 |
Gómez, Y | 1 |
Sharquie, KE | 1 |
Najim, RA | 1 |
Al-Hayani, RK | 1 |
Al-Nuaimy, AA | 1 |
Maroof, DM | 1 |
Sinha, MR | 1 |
Gouet, D | 2 |
Marechaud, R | 2 |
Neau, JP | 1 |
Abadie, JC | 1 |
Rossi, F | 1 |
Sudre, Y | 1 |
Levy, L | 3 |
Ji, BH | 2 |
Chen, JK | 1 |
Zhang, JL | 1 |
Hou, YH | 1 |
Ni, GX | 1 |
Zhang, RB | 1 |
Jesudasan, K | 4 |
Christian, M | 4 |
Bradley, D | 1 |
Convit, J | 1 |
Goihman-Yahr, M | 1 |
Rondón-Lugo, AJ | 1 |
Pattyn, SR | 6 |
Eyckmans, L | 1 |
Gigase, P | 1 |
Mathur, NK | 1 |
Bumb, RA | 1 |
Mangal, HN | 1 |
Yamasaki, R | 1 |
Dekio, S | 1 |
Moriyasu, S | 1 |
Takagaki, K | 1 |
Plechistova, LA | 1 |
Salikhov, AS | 1 |
Soares, DJ | 1 |
Neupane, K | 1 |
Britton, WJ | 1 |
Smith, TC | 1 |
Richardus, JH | 1 |
Maier, H | 1 |
Diem, E | 1 |
Gotschim, A | 1 |
Ortel, B | 1 |
Katoch, K | 2 |
Yadav, VS | 1 |
Bhatia, AS | 2 |
Hoernle, EH | 1 |
Reid, TE | 1 |
Lee, MW | 1 |
Nixon, RL | 1 |
Saah, AJ | 1 |
Hoover, DR | 1 |
Peng, Y | 1 |
Phair, JP | 1 |
Visscher, B | 1 |
Kingsley, LA | 1 |
Schrager, LK | 1 |
Hernández, F | 1 |
Linares, M | 1 |
Colomina, P | 1 |
Pastor, E | 1 |
Cerveró, A | 1 |
Pérez, A | 1 |
Perella, M | 1 |
Epstein, LJ | 1 |
Meyer, RD | 1 |
Antonson, S | 1 |
Strigle, SM | 1 |
Mohsenifar, Z | 1 |
Jamet, P | 3 |
Blanc, L | 1 |
Fayne, OC | 1 |
Traore, I | 2 |
Bobin, P | 1 |
Cartel, JL | 3 |
Naudin, JC | 1 |
Liozon, F | 1 |
Vidal, E | 1 |
Boutros-Toni, F | 1 |
Gaches, F | 1 |
Loustaud-Ratti, V | 1 |
Berdah, JF | 1 |
Honoré, N | 1 |
Perrani, E | 1 |
Telenti, A | 1 |
Grosset, J | 1 |
Ghys, P | 1 |
Janssens, L | 2 |
Tshilumba, K | 1 |
Kuykens, L | 3 |
Karibushi, N | 1 |
Denis, P | 1 |
Schadendorf, D | 1 |
Haas, N | 1 |
Nürnberger, F | 1 |
Czarnetzki, BM | 1 |
Li, HY | 1 |
Nadkarni, NJ | 1 |
Grugni, A | 1 |
Kini, MS | 1 |
Chauhan, SL | 1 |
Malaviya, GN | 1 |
Husain, S | 1 |
Mukherjee, A | 1 |
Schofield, JK | 1 |
Tatnall, FM | 1 |
Leigh, IM | 1 |
Richards, FO | 1 |
Kovacs, JA | 2 |
Luft, BJ | 1 |
Ashiru, JO | 1 |
Ijaduola, GT | 1 |
Aghadiuno, PU | 1 |
Adeyemi, FA | 1 |
Akang, EE | 1 |
Shear, NH | 1 |
Knowles, SR | 1 |
Shapiro, L | 1 |
Poldre, P | 1 |
Cribier, B | 1 |
Cuny, JF | 1 |
Schubert, B | 1 |
Colson, A | 1 |
Truchetet, F | 1 |
Grosshans, E | 1 |
Ena, P | 1 |
Lissia, M | 1 |
Doneddu, GM | 1 |
Campus, GV | 1 |
MacDonald, RD | 1 |
McGuigan, MA | 1 |
de Carsalade, GY | 1 |
Wallach, D | 2 |
Spindler, E | 1 |
Pennec, J | 2 |
Cottenot, F | 2 |
Flageul, B | 2 |
Sow, S | 1 |
Perani, EG | 1 |
Grosset, JH | 3 |
Marbiah, NT | 1 |
Petersen, E | 1 |
David, K | 1 |
Magbity, E | 1 |
Lines, J | 1 |
Bradley, DJ | 1 |
Sehgal, VN | 1 |
Kumar, S | 1 |
Jain, S | 1 |
Bhattacharya, SN | 1 |
Dubost-Brama, A | 1 |
Delaporte, E | 1 |
Catteau, B | 1 |
Warembourg, A | 1 |
Piette, F | 1 |
Bergoend, H | 1 |
Rausing, A | 1 |
Havelius, U | 1 |
Sucker, C | 1 |
Djawari, J | 1 |
Albrecht, J | 1 |
Mempel, M | 1 |
Hein, R | 1 |
Abeck, D | 1 |
Ring, J | 1 |
Chen, XS | 1 |
Ye, GY | 1 |
Mahendran, R | 1 |
Grant, JW | 1 |
Norris, PG | 1 |
Galaria, NA | 1 |
Junkins-Hopkins, JM | 1 |
Kligman, D | 1 |
James, WD | 1 |
Shaw, IN | 2 |
Ebenezer, G | 1 |
Rao, GS | 2 |
Natrajan, MM | 2 |
Balasundaram, B | 1 |
Aramaki, J | 1 |
Happle, R | 1 |
Kaklamani, VG | 1 |
Kaklamanis, PG | 1 |
Kavitha, M | 1 |
Ahmed, AR | 1 |
Colón, JE | 1 |
DiCaudo, DJ | 1 |
Connolly, SM | 1 |
Assicot, C | 1 |
Bourrat, E | 1 |
Prigent, F | 1 |
Moraillon, I | 1 |
Vignon, MD | 1 |
Triller, R | 1 |
Rybojad, M | 1 |
Pearson, JM | 1 |
Rees, RJ | 2 |
Waters, MF | 2 |
Warren, G | 1 |
Faber, WR | 1 |
Leiker, DL | 4 |
Yoder, L | 1 |
Naafs, B | 1 |
Harboe, M | 1 |
Bjune, G | 1 |
Nair, KK | 1 |
Russell, DA | 2 |
Worth, RM | 1 |
Jano, B | 1 |
Fasal, P | 1 |
Shepard, CC | 2 |
Ramu, G | 2 |
Haim, S | 2 |
Friedman-Birnbaum, R | 2 |
Jacobson, RR | 2 |
Trautman, JR | 1 |
Neelan, PN | 1 |
Ganapati, R | 1 |
Dongre, VV | 1 |
McRae, DH | 1 |
Scott, GC | 1 |
Vincin, DR | 1 |
Becx-Bleumink, M | 2 |
Martin, MA | 1 |
Cox, PH | 1 |
Beck, K | 1 |
Styer, CM | 1 |
Beall, GN | 1 |
Groenen, G | 2 |
Bourland, J | 1 |
Grillone, G | 1 |
Stes, P | 1 |
Venning, VA | 2 |
Wojnarowska, F | 2 |
Taïeb, A | 1 |
Bassan-Andrieu, L | 1 |
Maleville, J | 1 |
González Quijada, S | 1 |
López Lázaro, L | 1 |
Reinares García, L | 1 |
Borregón Carretero, SJ | 1 |
Sastre Varela, J | 1 |
Estrada Pérez, V | 1 |
Pandian, TD | 1 |
Muliyil, J | 1 |
Vellut, C | 1 |
Neumann, R | 1 |
Tauber, J | 1 |
Foster, CS | 1 |
Mputu, LB | 1 |
Boutin, JP | 1 |
Spiegel, A | 1 |
Plichart, R | 1 |
Roux, JF | 1 |
Blok, LM | 1 |
Bloos, LJ | 1 |
van den Berg, G | 1 |
Zaun, H | 1 |
Lichter, MD | 1 |
Welykyj, SE | 1 |
Gradini, R | 1 |
Solomon, LM | 1 |
Constant-Desportes, M | 1 |
Guelpa-Lauras, CC | 1 |
Carolina, JC | 1 |
Léoture, A | 1 |
Sansarricq, H | 1 |
Husser, JA | 1 |
Baquillon, G | 1 |
Maiga, M | 1 |
Vignon-Pennamen, MD | 1 |
Reddy, RN | 1 |
Warndorff van Diepen, T | 1 |
Mengistu, G | 1 |
Lidman, C | 1 |
Ortqvist, A | 1 |
Lundbergh, P | 1 |
Julander, I | 1 |
Bergdahl, S | 1 |
Millard, PR | 1 |
Ramanathan, U | 1 |
Bagga, AK | 1 |
Saxena, RK | 1 |
Kurz, XM | 1 |
Declercq, EE | 1 |
Vellut, CM | 1 |
Ekambaram, V | 1 |
Rao, MK | 1 |
Le Berre, D | 1 |
Alcalay, M | 1 |
Becq-Giraudon, B | 1 |
Boissonnot, L | 1 |
Bontoux, D | 1 |
Gil, R | 1 |
Lefevre, JP | 1 |
Risse, JF | 1 |
Hu, YM | 1 |
Wang, XX | 1 |
Deng, BZ | 1 |
Liu, FA | 1 |
Zhu, QP | 1 |
Kuang, MS | 1 |
Masur, H | 1 |
Pavithran, K | 1 |
Rao, CK | 1 |
Mittal, BN | 1 |
Dharmshaktu, NS | 1 |
Ramachandran, A | 1 |
Seshadri, PS | 1 |
Reddy, PK | 1 |
Mohinuddin, SK | 1 |
Kleeberg, HH | 1 |
Smith, KC | 1 |
Pittelkow, MR | 1 |
Su, WP | 1 |
Andrade Filho, Ade S | 1 |
de Sena, PG | 1 |
Bittencourt, AL | 1 |
Sadigursky, M | 1 |
Naudillon, Y | 1 |
Remy, JC | 1 |
Almeida, JG | 1 |
Chacko, CJ | 1 |
Onsun, N | 1 |
Saylan, T | 1 |
Tribbia, G | 1 |
Pezzoli, G | 1 |
Gelmetti, C | 1 |
Cucchi, G | 1 |
Tettamanti, A | 1 |
Giunta, A | 1 |
Gianotti, F | 1 |
Laing, AB | 1 |
Meade, TW | 1 |
Parikshak, N | 1 |
North, WR | 1 |
Meyer, O | 1 |
Ryckewaert, A | 1 |
DeMento, FJ | 1 |
Grover, RW | 1 |
Hall, AP | 2 |
Barrett-Connor, E | 1 |
Schewach Millet, M | 1 |
Ziprkowski, L | 1 |
Feinstein, A | 1 |
Cvibah, T | 1 |
Peters, JH | 1 |
Gordon, GR | 1 |
Strokan, MA | 1 |
Enna, CD | 1 |
Kirchheimer, WF | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Independent Study to Establish the Efficacy of the Six Doses Uniform MDT Regimen (U-MDT) for Leprosy Patients[NCT00669643] | Phase 4 | 859 participants (Actual) | Interventional | 2007-02-28 | Completed | ||
Prospective Multicenter Randomized Open-label Controlled Trial Assessing Efficacy and Safety of DAPSone as a Second-line Option in Adult Immune Thrombocytopenia[NCT02627417] | Phase 3 | 216 participants (Anticipated) | Interventional | 2015-12-31 | Recruiting | ||
Rituximab in the Treatment of Patients With Bullous Pemphigoid[NCT00286325] | Phase 1/Phase 2 | 8 participants (Actual) | Interventional | 2005-03-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Peripheral blood B cell number at week 24 compared to B cell number at week 0 (NCT00286325)
Timeframe: Week 0 and at 24 weeks
Intervention | B cells per microliter (Median) |
---|---|
Treated | 3.99 |
IgG antibodies against BP 180 measured in units (by ELISA) for each participant at week 0 compared to value at week 24, (NCT00286325)
Timeframe: Week 0 and at 24 weeks
Intervention | Elisa Units (Median) |
---|---|
Treated | 40.5 |
The first study visit in which patient reported and was confirmed to have no new blister or lesion formation . (NCT00286325)
Timeframe: 1 year
Intervention | Days (Median) |
---|---|
Treated | 57 |
Subject systemic corticosteroid dosage at week 24 was 25% of starting dose or 10 mg/day of prednisone or less (NCT00286325)
Timeframe: 24 weeks
Intervention | participants (Number) |
---|---|
Treated | 7 |
The primary safety endpoint is the occurrence of treatment emergent adverse events including infections, infusion reactions and disease progression. These were determined by clinical evaluation and laboratory questions. Disease progression is defined as development of new blisters despite therapy. These are reported as the number of participants with a study related SAE. (NCT00286325)
Timeframe: 1 year
Intervention | participants (Number) | ||
---|---|---|---|
Treatment emergent adverse events | Infusion reactions | Disease Progression | |
Treated | 0 | 0 | 1 |
21 reviews available for dapsone and Recrudescence
Article | Year |
---|---|
Risk factors for dapsone resistance in leprosy patients: a systematic meta-analysis.
Topics: Dapsone; Humans; Leprosy; Mycobacterium leprae; Recurrence; Risk Factors | 2022 |
A 13-year-old girl with recurrent oral ulcers.
Topics: Adolescent; Autoimmune Diseases; Dapsone; Diagnosis, Differential; Female; Humans; Mouth Mucosa; Ora | 2019 |
Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis.
Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Dap | 2014 |
Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives.
Topics: Anti-Bacterial Agents; Azathioprine; Behcet Syndrome; Colchicine; Dapsone; Humans; Interferon-alpha; | 2015 |
Subcorneal Pustular Dermatosis: A Review of 30 Years of Progress.
Topics: Connective Tissue Diseases; Dapsone; Diagnosis, Differential; Glucocorticoids; Hematologic Diseases; | 2016 |
Pemphigus foliaceus with circinated plaques and neutrophil pustules.
Topics: Dapsone; Female; Humans; Neutrophils; Pemphigus; Prednisolone; Recurrence; Young Adult | 2016 |
[Giant cell arteritis].
Topics: Adrenal Cortex Hormones; Aged, 80 and over; Anti-Infective Agents; Biopsy; Blood Sedimentation; C-Re | 2008 |
Progressive keratolysis with pseudopterygium associated with erythema elevatum diutinum.
Topics: Anti-Infective Agents; Corneal Ulcer; Dapsone; Female; Humans; Middle Aged; Pterygium; Recurrence; S | 2011 |
[Bullous pemphigoid: a review].
Topics: Aged; Azathioprine; Clobetasol; Combined Modality Therapy; Dapsone; Dose-Response Relationship, Drug | 2011 |
Evolution of the modern chemotherapy of leprosy.
Topics: Animals; Clofazimine; Dapsone; Drug Evaluation; Drug Evaluation, Preclinical; Drug Resistance, Micro | 1983 |
Human immunodeficiency virus infection in children.
Topics: Adolescent; AIDS-Related Opportunistic Infections; Child; Child, Preschool; Dapsone; Didanosine; Dru | 1995 |
[Clinical course of Horton disease. Apropos of 42 cured patients].
Topics: Aged; Aged, 80 and over; Dapsone; Female; Giant Cell Arteritis; Humans; Male; Middle Aged; Prednison | 1994 |
Preventing toxoplasmic encephalitis in persons infected with human immunodeficiency virus.
Topics: AIDS-Related Opportunistic Infections; Animals; Anti-Infective Agents; Cats; Dapsone; Drug Therapy, | 1995 |
Rhinosporodium: case report.
Topics: Adolescent; Anti-Infective Agents; Combined Modality Therapy; Dapsone; Female; Humans; Nasal Polyps; | 1996 |
Dapsone in prevention of recurrent neutrophilic eccrine hidradenitis.
Topics: Antineoplastic Agents; Dapsone; Hidradenitis; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; | 1996 |
Erosive pustular dermatosis of the scalp in skin grafts: report of three cases.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Anti-Bacterial Agents; Anti-Infective Agents; | 1997 |
Dapsone-responsive persistent erythema multiforme.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Erythema Multiforme; Fema | 2000 |
Relapses among leprosy patients treated with multidrug therapy: experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia; practical difficulties with diagnosing relapses; operational proced
Topics: Clofazimine; Dapsone; Epidemiologic Methods; Ethiopia; Humans; Incidence; Leprostatic Agents; Lepros | 1992 |
Pneumocystis carinii pneumonia: therapy and prophylaxis.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Dapsone; Drug Combinations; Drug Therapy, | 1988 |
Prevention of Pneumocystis carinii pneumonia.
Topics: Acquired Immunodeficiency Syndrome; Aerosols; Dapsone; Drug Combinations; Humans; Pentamidine; Pneum | 1988 |
Panniculitis associated with severe alpha 1-antitrypsin deficiency. Treatment and review of the literature.
Topics: Adipose Tissue; Adult; Aged; alpha 1-Antitrypsin; alpha 1-Antitrypsin Deficiency; Biopsy; Blood Prot | 1987 |
21 trials available for dapsone and Recrudescence
Article | Year |
---|---|
Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brazil; Child; Child, Preschool; Clofazimine; Dapsone; D | 2017 |
Systemic treatment in severe cases of recurrent aphthous stomatitis: an open trial.
Topics: Adolescent; Adult; Aged; Child; Colchicine; Dapsone; Drug Administration Schedule; Female; Follow-Up | 2009 |
The efficacy of a four-week, ofloxacin-containing regimen compared with standard WHO-MDT in PB leprosy.
Topics: Adult; Dapsone; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; L | 2010 |
Dapsone salvage therapy for adult patients with immune thrombocytopenia relapsed or refractory to steroid and rituximab.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Contraindications; Dan | 2012 |
Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial.
Topics: Antimalarials; Cause of Death; Child, Preschool; Dapsone; Developing Countries; Drug Combinations; D | 2002 |
Relapses in multibacillary patients treated with multi-drug therapy until smear negativity: findings after twenty years.
Topics: Acedapsone; Aged; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Follow-Up Studies; Humans | 2004 |
The therapeutic and prophylactic role of oral zinc sulfate in management of recurrent aphthous stomatitis (ras) in comparison with dapsone.
Topics: Administration, Oral; Adolescent; Adult; Analysis of Variance; Anti-Infective Agents; Astringents; C | 2008 |
Relapse rates among nonlepromatous patients released from control.
Topics: Adolescent; Adult; Child; Clinical Trials as Topic; Dapsone; Female; Humans; Leprosy; Male; Recurren | 1984 |
A randomized clinical trial of two single-dose treatments for paucibacillary leprosy.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Clofazimine; Dapsone; Drug Administration Schedule | 1994 |
Daily multidrug therapy for leprosy; results of a fourteen-year experience.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Clofazimine; Dapsone; Drug Resistance, Microbial; | 1997 |
High relapse rate among lepromatous leprosy patients treated with rifampin plus ofloxacin daily for 4 weeks.
Topics: Adult; Anti-Infective Agents; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Fema | 1997 |
A controlled trial of lambda-cyhalothrin-impregnated bed nets and/or dapsone/pyrimethamine for malaria control in Sierra Leone.
Topics: Anti-Infective Agents; Bedding and Linens; Child; Child, Preschool; Dapsone; Humans; Infant; Insecti | 1998 |
Long-term follow up of multibacillary leprosy patients with high BI treated with WHO/MDT regimen for a fixed duration of two years.
Topics: Adult; Clofazimine; Cohort Studies; Dapsone; Drug Therapy, Combination; Female; Follow-Up Studies; H | 2000 |
Evaluation of treatment of lepromatous leprosy patients in the Netherlands.
Topics: Clinical Trials as Topic; Clofazimine; Dapsone; Drug Evaluation; Humans; Leprostatic Agents; Leprosy | 1979 |
Clinical trial of diaminodiphenylsulfone (DDS) in nasal and nasopharyngeal rhinosporidiosis.
Topics: Dapsone; Drug Evaluation; Humans; Nasopharyngeal Diseases; Nose Diseases; Recurrence; Rhinosporidios | 1979 |
Rifampin therapy of lepromatous leprosy.
Topics: Acetamides; Animals; Clinical Trials as Topic; Dapsone; Drug Administration Schedule; Erythema Nodos | 1975 |
Acedapsone (DADDS) treatment of leprosy patients in the Karimui of Papua New Guinea: status at six years.
Topics: Acetamides; Adolescent; Adult; Aged; Bacterial Infections; Child; Child, Preschool; Clinical Trials | 1975 |
A controlled therapeutic trial in paucibacillary leprosy comparing a single dose of rifampicin with a single dose of rifampicin followed by one year of daily dapsone. The Collaborative Study Group for the Treatment of Leprosy in Zaire.
Topics: Dapsone; Democratic Republic of the Congo; Drug Administration Schedule; Drug Therapy, Combination; | 1991 |
Evaluation of five treatment regimens, using either dapsone monotherapy or several doses of rifampicin in the treatment of paucibacillary leprosy.
Topics: Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Humans; Leprosy; Mycobacterium lep | 1990 |
Relapse rate and incidence of dapsone resistance in lepromatous leprosy patients in Addis Ababa: risk factors and effect of short-term supplementary treatment.
Topics: Adolescent; Adult; Dapsone; Drug Combinations; Drug Resistance; Humans; Isoniazid; Leprosy; Recurren | 1985 |
Pulmonary tuberculosis treated with isoprodian and rifampicin or pyrazinamide.
Topics: Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Dapsone; Drug Combinations; Drug Thera | 1987 |
145 other studies available for dapsone and Recrudescence
Article | Year |
---|---|
Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan.
Topics: Anti-Bacterial Agents; Brazil; Cross-Sectional Studies; Dapsone; Drug Resistance, Bacterial; Drug Th | 2022 |
Omalizumab in the Treatment of Chronic Urticaria: The Effect of Drug Co-Administration and Co-Morbidities.
Topics: Anti-Allergic Agents; Chronic Urticaria; Comorbidity; Cyclosporine; Dapsone; Drug Therapy, Combinati | 2021 |
Low rate of relapse after twelve-dose multidrug therapy for hansen's disease: A 20-year cohort study in a brazilian reference center.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brazil; Child; Child, Preschool; Clofazimine; Dapsone; D | 2021 |
Multiple cranial nerve palsies secondary to a recurrence of Hansen's disease.
Topics: Adult; Cranial Nerve Diseases; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Humans; | 2018 |
Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009-15.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Biopsy, Needle; Brazil; Colombia; Dapsone; DNA Gyrase; Dr | 2018 |
Widespread Dermatophytosis in a Patient Treated for Leprosy Type II Reactional State after MDT/WHO-MB Release.
Topics: Antifungal Agents; Brazil; Dapsone; Erythema Nodosum; Humans; Leprostatic Agents; Leprosy, Lepromato | 2018 |
Recurrent acute hemorrhagic edema of infancy (AHEI) during puberty.
Topics: Acute Disease; Adolescent; Age of Onset; Dapsone; Ecchymosis; Edema; Female; Hemorrhage; Humans; Pub | 2018 |
Recurrent Neurological Episodes for 10 Years Preceding Skin Lesions in Neuro-Sweet Disease.
Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Anti-Infective Agents; Dapsone; Diagnosis, Dif | 2019 |
[Efficacy of acitretin in IgA pemphigus].
Topics: Acitretin; Aged, 80 and over; Betamethasone; C-Reactive Protein; Dapsone; Female; Humans; Immunoglob | 2013 |
Treatment of giant cellulitis-like Sweet syndrome with dapsone.
Topics: Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Dapsone; Female; Humans; Middle Aged; Prednis | 2014 |
[Verneuil's disease: a real therapeutic challenge].
Topics: Acne Keloid; Adult; Chronic Disease; Dapsone; Folliculitis; Humans; Male; Recurrence | 2014 |
Neuro-Sweet's disease.
Topics: Adult; Anti-Inflammatory Agents; Brain Diseases; Dapsone; Drug Therapy, Combination; Humans; Male; M | 2016 |
Efficacy of Dapsone in the Treatment of Pemphigus Vulgaris: A Single-Center Case Study.
Topics: Adult; Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Dapsone; Drug Therapy, Combination; Fe | 2016 |
Leprosy Drug Resistance Surveillance in Colombia: The Experience of a Sentinel Country.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Proteins; Child; Colombia; Dapsone; DNA, Bacte | 2016 |
Treatment of antiviral-resistant recurrent erythema multiforme with dapsone.
Topics: Adolescent; Adult; Anti-Infective Agents; Antiviral Agents; Dapsone; Drug Resistance; Erythema Multi | 2017 |
Two microbiological relapses in a patient with lepromatous leprosy.
Topics: Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Humans; Leprostatic Agents; Lepros | 2008 |
Sweet-like dermatosis in 2 patients with clinical features of dermatomyositis and underlying autoimmune disease.
Topics: Aged; Autoimmune Diseases; Biopsy, Needle; Dapsone; Dermatomyositis; Female; Follow-Up Studies; Gran | 2008 |
Successful treatment of complex aphthosis with colchicine and dapsone.
Topics: Adult; Anti-Inflammatory Agents; Colchicine; Dapsone; Drug Administration Schedule; Drug Therapy, Co | 2009 |
Drug-to-drug interaction between dapsone and minocycline: an unusual cause of relapse of toxoplasmic encephalitis in an HIV-infected patient.
Topics: Adult; Dapsone; Drug Interactions; Encephalitis; HIV Infections; HIV-1; Humans; Male; Minocycline; R | 2009 |
Twenty five years follow up of MB leprosy patients retreated with a modified MDT regimen after a full course of dapsone mono-therapy.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Dapsone; Drug Therapy, Combination; Female; Follow-U | 2009 |
Bullous pemphigoid masquerading as recurrent vesicular hand eczema.
Topics: Adrenal Cortex Hormones; Autoantibodies; Autoantigens; Basement Membrane; Collagen Type XVII; Comple | 2010 |
Very late relapse of dapsone-induced methaemoglobinemia.
Topics: Adult; Anti-Bacterial Agents; Dapsone; Dermatitis; Female; Humans; Immunosuppressive Agents; Lupus E | 2010 |
[Erythema elevatum diutinum associated with pyoderma gangrenosum in an HIV-positive patient].
Topics: Dapsone; Dermis; Erythema; Foot Diseases; HIV Infections; Humans; Male; Middle Aged; Neutrophils; Py | 2010 |
Relapse study in smear positive multibacillary (MB) leprosy after 1 year WHO-multi-drug therapy (MDT) in Cebu, Philippines.
Topics: Adolescent; Adult; Aged; Child; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Lep | 2011 |
Dapsone therapy for hidradenitis suppurativa: a series of 24 patients.
Topics: Adult; Dapsone; Dermatologic Agents; Female; Glucosephosphate Dehydrogenase; Hidradenitis Suppurativ | 2011 |
Present situation of leprosy in Japan, 2006-2010: analysis of drug resistance in new registered and relapsed cases by molecular biological methods.
Topics: Adult; Aged; Dapsone; Drug Resistance, Bacterial; Female; Humans; Japan; Leprostatic Agents; Leprosy | 2012 |
Rhinosporidiosis in southwest Bengal.
Topics: Adolescent; Animals; Anti-Infective Agents; Child; Dapsone; Female; Humans; India; Male; Nasopharyng | 2012 |
[Recurrent anemia in a 22-year-old woman].
Topics: Anemia, Hemolytic; Australia; Dapsone; Diagnosis, Differential; Female; Humans; Munchausen Syndrome; | 2012 |
Oral aphthosis: management gaps and recent advances.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Anti-Inf | 2012 |
Long-term effectiveness of danazol corticosteroids and cytotoxic drugs in the treatment of hematologic manifestations of systemic lupus erythematosus.
Topics: Adult; Anemia, Hemolytic; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathio | 2003 |
Short report: Treatment failure in Hansen's disease.
Topics: Adolescent; Adult; Aged; Child; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Lep | 2003 |
[Two cases of Hansen's disease].
Topics: Aged; Dapsone; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Male; Recurrence; Rif | 2003 |
Long-term remission in patients with dermatitis herpetiformis on a normal diet.
Topics: Adolescent; Adult; Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Child; Child, Preschool; Co | 2003 |
A bullous neutrophilic dermatosis in a patient with severe rheumatoid arthritis and monoclonal IgA gammopathy.
Topics: Adult; Arthritis, Rheumatoid; Biopsy; Dapsone; Dermatitis Herpetiformis; Diagnosis, Differential; Hu | 2004 |
Sweet's syndrome associated with Staphylococcus aureus.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Female; Follow-Up Studies; Humans; Middle Aged; Pr | 2004 |
Artesunate-dapsone-proguanil treatment of falciparum malaria: genotypic determinants of therapeutic response.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Dapsone; Dihydropteroate Syntha | 2005 |
[Reversible lower limb lymphedema as the first manifestation of cutaneous periarteritis nodosa].
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Dapsone; Diagnosis, D | 2005 |
Borderline lepromatous leprosy presenting as a single cutaneous plaque.
Topics: Administration, Oral; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Forearm; Glucocorticoi | 2005 |
Trends of case detection and other indicators of leprosy in China during 1985-2002.
Topics: Adolescent; Adult; Age Factors; Child; China; Communicable Disease Control; Dapsone; Disability Eval | 2005 |
Treatment of bullous pemphigoid with dapsone, methylprednisolone, and topical clobetasol propionate: a retrospective study of 62 cases.
Topics: Administration, Oral; Administration, Topical; Aged; Anti-Inflammatory Agents; Clobetasol; Dapsone; | 2005 |
[Hemorrhages in the fingers of a 45-year-old woman].
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Celiac Disease; Dapsone; Derm | 2003 |
Dihydropteroate synthase mutations in the folP1 gene predict dapsone resistance in relapsed cases of leprosy.
Topics: Animals; Dapsone; Dihydropteroate Synthase; Dose-Response Relationship, Drug; Drug Resistance, Bacte | 2006 |
Disseminated rhinosporidiosis - an unusual presentation with pulmonary involvement.
Topics: Animals; Anti-Infective Agents; Dapsone; Follow-Up Studies; Foot Ulcer; Humans; Lung Diseases; Male; | 2006 |
Dapsone in the treatment of persistent erythema multiforme.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Erythema Multiforme; Female; Humans; Middle Aged; | 2006 |
Epidemiology of leprosy and response to treatment in Hong Kong.
Topics: Clofazimine; Dapsone; Drug Resistance, Bacterial; Drug Therapy, Combination; Hong Kong; Humans; Inci | 2006 |
Successful treatment of relapsing neuro-Sweet's disease with corticosteroid and dapsone combination therapy.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Anti-Inflammatory Agents; Biopsy; Brain; Dapsone | 2007 |
[Study of rifampin and dapsone resistance in three patients with recurring leprosy].
Topics: Aged; Dapsone; DNA, Bacterial; Drug Resistance, Microbial; Humans; Leprostatic Agents; Leprosy; Male | 2008 |
Fixed genital drug eruption due to dapsone. A case report.
Topics: Adult; Dapsone; Drug Eruptions; Female; Genital Diseases, Female; Humans; Leprosy; Recurrence | 1982 |
[Chronic atrophic polychondritis. Critical analysis of the therapeutic efficacy of dapsone. 2 cases].
Topics: Aged; Anemia, Hemolytic; Dapsone; Ear Cartilage; Ear Deformities, Acquired; Humans; Male; Middle Age | 1984 |
Secondary dapsone-resistant leprosy in Shanghai Municipality.
Topics: Animals; Dapsone; Drug Resistance, Microbial; Female; Humans; Leprosy; Male; Mice; Mycobacterium lep | 1983 |
[Secondary dapsone resistance in leprotic patients of the Shanghai district].
Topics: Animals; China; Dapsone; Drug Resistance, Microbial; Female; Humans; Leprosy; Male; Mice; Recurrence | 1983 |
Effectiveness of dapsone in Behcet's disease.
Topics: Behcet Syndrome; Dapsone; Humans; Recurrence; Stomatitis, Aphthous | 1984 |
Late reversal reaction after combined treatment of a patient with multibacillary leprosy.
Topics: Dapsone; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Prothion | 1984 |
Oral zinc in recurrent Erythema Nodosum Leprosum reaction.
Topics: Administration, Oral; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Erythema Nodosum; Fema | 1983 |
Three cases of prurigo pigmentosa.
Topics: Dapsone; Humans; Male; Middle Aged; Pigmentation Disorders; Prurigo; Recurrence; Sulfamethoxazole | 1981 |
[Long-term use of DDS by patients with Duhring's herpetiform dermatitis].
Topics: Dapsone; Dermatitis Herpetiformis; Humans; Male; Middle Aged; Recurrence; Time Factors | 1981 |
Relapse with multibacillary leprosy caused by rifampicin sensitive organisms following paucibacillary multidrug therapy.
Topics: Adult; Dapsone; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Leprostatic A | 1995 |
Relapse rates in patients treated with dapsone monotherapy and combinations of dapsone and thiambutosine, thiacetazone, isoniazid and streptomycin in the pre-MDT era.
Topics: Dapsone; Drug Therapy, Combination; Female; Humans; Isoniazid; Leprostatic Agents; Leprosy; Male; Ph | 1994 |
[Pyoderma gangrenosum as a precursor of myeloid leukemia].
Topics: Adult; Combined Modality Therapy; Cyclosporine; Dapsone; Female; Follow-Up Studies; Humans; Leukemia | 1995 |
Response of leprosy patients with single lesions to MDT.
Topics: Adolescent; Adult; Arm; Dapsone; Drug Therapy, Combination; Facial Dermatoses; Follow-Up Studies; Hu | 1995 |
Eosinophilic cellulitis case report: treatment options.
Topics: Administration, Oral; Cellulitis; Cetirizine; Cyproheptadine; Dapsone; Drug Therapy, Combination; Eo | 1994 |
Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study.
Topics: Adult; AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; Dapsone; HIV Infections; HIV-1; | 1995 |
Dapsone for refractory chronic idiopathic thrombocytopenic purpura.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chronic Disease; Dapsone; Female; Humans; Middle Aged; P | 1995 |
Persistence of Pneumocystis carinii in patients with AIDS receiving chemoprophylaxis.
Topics: Adult; AIDS-Related Opportunistic Infections; Bronchoalveolar Lavage Fluid; Dapsone; Humans; Male; M | 1994 |
Relapses after a single dose of rifampin in skin-smear negative multibacillary patients after dapsone monotherapy.
Topics: Adult; Aged; Confidence Intervals; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; | 1994 |
Rate of relapse in multibacillary patients after cessation of long-course dapsone monotherapy supplemented by a final supervised single dose of 1500 mg of rifampin.
Topics: Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; | 1994 |
A simple and rapid technique for the detection of rifampin resistance in Mycobacterium leprae.
Topics: Alleles; Amino Acid Sequence; Base Sequence; Dapsone; DNA Primers; DNA-Directed RNA Polymerases; DNA | 1993 |
[Recurrent nodular panniculitis in alpha 1-antitrypsin deficiency. Successful dapsone therapy].
Topics: alpha 1-Antitrypsin Deficiency; Complement C3; Dapsone; Diagnosis, Differential; Female; Fluorescent | 1993 |
Problems of leprosy relapse in China.
Topics: China; Clofazimine; Dapsone; Drug Therapy, Combination; Follow-Up Studies; Humans; Leprosy; Recurren | 1993 |
Fixed duration MDT in paucibacillary leprosy (classical and modified).
Topics: Dapsone; Drug Therapy, Combination; Follow-Up Studies; Humans; Leprostatic Agents; Leprosy; Recurren | 1993 |
Borderline-tuberculoid relapse in lepromatous leprosy.
Topics: Dapsone; Female; Humans; Leprosy, Borderline; Leprosy, Lepromatous; Leprosy, Tuberculoid; Male; Midd | 1993 |
Recurrent erythema multiforme: clinical features and treatment in a large series of patients.
Topics: Acyclovir; Administration, Oral; Adolescent; Adult; Aged; Azathioprine; Child; Child, Preschool; Chr | 1993 |
Recurrent annular erythema with purpura: a new variant of leucocytoclastic vasculitis responsive to dapsone.
Topics: Dapsone; Female; Humans; Male; Middle Aged; Recurrence; Skin; Vasculitis, Leukocytoclastic, Cutaneou | 1996 |
Acute dapsone intoxication: a pediatric case report.
Topics: Antimalarials; Charcoal; Child, Preschool; Dapsone; Humans; Male; Methemoglobinemia; Methylene Blue; | 1997 |
Relapse (reactivation) in borderline tuberculoid (BT) leprosy.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Dapsone; Drug Monitoring; Granuloma; Histiocyte | 1998 |
[Ofuji's eosinophilic pustular folliculitis. Efficacy of acitretin].
Topics: Acitretin; Dapsone; Eosinophils; Facial Dermatoses; Female; Folliculitis; Humans; Isotretinoin; Kera | 1997 |
Pterygium with granuloma faciale-like histologic picture.
Topics: Aged; Conjunctival Diseases; Dapsone; Female; Granuloma; Humans; Pterygium; Recurrence | 1998 |
[Recurrent episodes of ulcerative gingivostomatitis associated with cyclic neutropenia].
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Dapsone; Gingivitis, Necrotizing Ulcerative; Humans; M | 1999 |
[Henoch-Schönlein purpura: successful treatment with Dapsone].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Follow-Up Studies; Humans; IgA Vasculitis; | 1999 |
Studies on risk of leprosy relapses in China: relapses after treatment with dapsone monotherapy.
Topics: China; Dapsone; Follow-Up Studies; Humans; Leprostatic Agents; Leprosy; National Health Programs; Po | 1999 |
Neutrophilic dermatosis of the dorsal hands: pustular vasculitis revisited.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Blister; Dapsone; Diagnosis, Differential; Female; Hand; Hu | 2000 |
Relapse as histoid leprosy after receiving multidrug therapy (MDT); a report of three cases.
Topics: Acedapsone; Adolescent; Adult; Animals; Child; Clofazimine; Dapsone; Drug Resistance, Microbial; Dru | 2000 |
[Prurigo pigmentosa].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Stero | 2001 |
Treatment of Behçet's disease--an update.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Behcet Syndrome; Chl | 2001 |
Comparison between intravenous immunoglobulin and conventional immunosuppressive therapy regimens in patients with severe oral pemphigoid: effects on disease progression in patients nonresponsive to dapsone therapy.
Topics: Adult; Aged; Dapsone; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunization, Pa | 2001 |
Neutrophilic dermatosis (pustular vasculitis) of the dorsal hands: a report of 7 cases and review of the literature.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Fe | 2002 |
[Cutaneous polyarteritis nodosa in children: three cases].
Topics: Adolescent; Adrenal Cortex Hormones; Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; C | 2002 |
Sulphone resistance in leprosy. A review of one hundred proven clinical cases.
Topics: Adolescent; Adult; Animals; Child; Dapsone; Drug Resistance, Microbial; Female; Humans; Leprosy; Mal | 1975 |
Clinical assessment and management of dapsone-resistant leprosy for the field worker.
Topics: Dapsone; Drug Resistance, Microbial; Humans; Leprosy; Mycobacterium leprae; Recurrence | 1977 |
Antibody activity against Mycobacterium leprae antigen 7 in leprosy: studies on variation in antibody content throughout the spectrum and on the effect of DDS treatment and relapse in BT leprosy.
Topics: Antibodies, Bacterial; Antigens, Bacterial; Dapsone; Humans; Leprosy; Mycobacterium leprae; Recurren | 1979 |
Workshop on "chemotherapy of leprosy" at the Central Leprosy Teaching and Research Institute, Chengalpattu (Tamil Nadu) on 21 January 1978.
Topics: Clofazimine; Dapsone; Humans; India; Leprosy; Recurrence; Rifampin; Thalidomide | 1979 |
Acedapsone in the prevention of leprosy: field trial in three high prevalence villages in Micronesia.
Topics: Acedapsone; Adult; Child; Dapsone; Drug Resistance, Microbial; Humans; Leprosy; Micronesia; Patient | 1979 |
[Chemotherapy of leprosy. I. Sulfones and sulfonamides].
Topics: Dapsone; Drug Resistance, Microbial; Drug Therapy, Combination; Erythema Nodosum; Humans; Leprostati | 1979 |
Treatment of steroid dependant cases of recurrent lepra reaction with a combination of thalidomide and clofazimine.
Topics: Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprosy; Male; Recurrence; Steroids; | 1979 |
Dapsone in the treatment of pemphigus vulgaris.
Topics: Adult; Dapsone; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Pemp | 1978 |
Srategy of leprosy control.
Topics: BCG Vaccine; Dapsone; Erythema Nodosum; Humans; Leprostatic Agents; Leprosy; Population Surveillance | 1978 |
Relaspe in leprosy.
Topics: Dapsone; Drug Resistance, Microbial; Humans; Leprosy; Recurrence | 1977 |
The diagnosis and treatment of leprosy.
Topics: Biopsy; Clofazimine; Dapsone; Erythema Nodosum; Humans; Immunotherapy; Leprosy; Recurrence; Rifampin | 1976 |
Inactivation and relapse in bacterio-negative cases of leprosy under sulphone therapy: a 4 1/2 years follow-up.
Topics: Dapsone; Female; Follow-Up Studies; Humans; Leprosy; Male; Recurrence | 1976 |
Clinical trial with clofazimine in leprosy.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Child; Clofazimine; Dapsone; Drug Therapy, Combination; | 1976 |
Relapses in leprosy patients after release from dapsone monotherapy; experience in the leprosy control program of the all Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
Topics: Adolescent; Adult; Child; Child, Preschool; Dapsone; Ethiopia; Eye Infections, Bacterial; Female; Hu | 1992 |
A comparison of the effectiveness of three regimens in the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Dapsone; Drug Administration Schedule; Drug Therapy | 1992 |
Eight years of follow-up of paucibacillary patients treated with short-course regimens.
Topics: Dapsone; Drug Therapy, Combination; Follow-Up Studies; Humans; Leprosy; Recurrence; Rifampin | 1992 |
Lack of predictive factors for the clinical course of bullous pemphigoid.
Topics: Aged; Aged, 80 and over; Autoimmune Diseases; Azathioprine; Dapsone; Drug Therapy, Combination; Fema | 1992 |
Eosinophilic pustulosis of the scalp in childhood.
Topics: Child, Preschool; Dapsone; Diagnosis, Differential; Eosinophilia; Female; Folliculitis; Humans; Infa | 1992 |
[Gastrointestinal involvement and the response to dapsone in a case of the urticarial vasculitis syndrome].
Topics: Adult; Chronic Disease; Dapsone; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Human | 1991 |
Risk of relapse among non-lepromatous patients released from treatment after dapsone monotherapy.
Topics: Adolescent; Adult; Child; Child, Preschool; Dapsone; Female; Humans; Infant; Leprosy; Male; Recurren | 1991 |
Remission and recurrence after withdrawal of therapy for ocular cicatricial pemphigoid.
Topics: Adult; Aged; Aged, 80 and over; Azathioprine; Cyclophosphamide; Dapsone; Female; Follow-Up Studies; | 1991 |
Longitudinal study on relapses of leprosy in Polynesian multibacillary patients on dapsone monotherapy between 1946 and 1970.
Topics: Dapsone; Humans; Leprosy; Longitudinal Studies; Polynesia; Probability; Recurrence; Risk | 1991 |
A retrospective study on seven years of multiple drug treatment for paucibacillary and multibacillary leprosy, in Bayara General Hospital, Nigeria.
Topics: Adolescent; Adult; Clofazimine; Dapsone; Drug Administration Schedule; Drug Resistance, Microbial; D | 1991 |
[Sulfones in alopecia areata].
Topics: Alopecia Areata; Dapsone; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Recurrence | 1991 |
Superficial granulomatous pyoderma.
Topics: Adult; Chronic Disease; Dapsone; Diagnosis, Differential; Granuloma; Humans; Male; Minocycline; Pyod | 1991 |
A case of relapse with drug-susceptible M. leprae after multidrug therapy.
Topics: Adult; Dapsone; Drug Therapy, Combination; Humans; Leprosy, Borderline; Leprosy, Lepromatous; Male; | 1991 |
[Late reversal reactions in leprosy].
Topics: Clofazimine; Dapsone; Drug Combinations; Ethionamide; Female; Humans; Leprosy; Male; Recurrence; Rif | 1990 |
Relapses in multibacillary leprosy.
Topics: Dapsone; Humans; Leprosy; Recurrence | 1990 |
Pneumocystis carinii pneumonia in Stockholm, Sweden: treatment, outcome, one-year-follow-up and pyrimethamine prophylaxis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Dapsone; Drug Evaluation; Drug Therapy, Combination | 1989 |
Dapsone as first line therapy for bullous pemphigoid.
Topics: Aged; Aged, 80 and over; Dapsone; Female; Humans; Male; Middle Aged; Pemphigoid, Bullous; Recurrence | 1989 |
Relapses in paucibacillary patients after treatment with three short-term regimens containing rifampin.
Topics: Adult; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lepromin; L | 1989 |
Rate and time distribution of relapses in multibacillary leprosy.
Topics: Dapsone; Humans; Leprosy; Recurrence; Retrospective Studies; Time Factors | 1989 |
Changing picture of leprosy in North Arcot District, Tamil Nadu after M.D.T.
Topics: Clofazimine; Cohort Studies; Dapsone; Drug Therapy, Combination; Follow-Up Studies; Humans; India; L | 1989 |
[Prognosis of treated temporal arteritis. Retrospective study of 87 cases].
Topics: Aged; Chloroquine; Cyclophosphamide; Dapsone; Drug Therapy, Combination; Female; Giant Cell Arteriti | 1986 |
[Action of nitroquine on tissue schizonts of Plasmodium cynomolgi].
Topics: Animals; Antimalarials; Dapsone; Female; Macaca mulatta; Malaria; Male; Plasmodium; Quinazolines; Re | 1986 |
Treatment of Pneumocystis carinii pneumonia.
Topics: Acquired Immunodeficiency Syndrome; Dapsone; Drug Combinations; Folic Acid Antagonists; Humans; Meth | 1987 |
Relapse of paucibacillary leprosy after short course multidrug therapy.
Topics: Adult; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leprosy, Tu | 1988 |
Leprosy control based on multi drug treatment in India.
Topics: Allied Health Personnel; Clofazimine; Dapsone; Data Collection; Drug Administration Schedule; Drug T | 1988 |
Relapse or reversal reaction: the case for a therapeutic trial of steroids.
Topics: Adult; Dapsone; Drug Therapy, Combination; Humans; Leprosy, Borderline; Male; Prednisolone; Recurren | 1988 |
Pattern of relapses in pauci-bacillary leprosy patients treated with M.D.T. (W.H.O. 1982).
Topics: Dapsone; Drug Therapy, Combination; Female; Humans; Leprosy; Male; Recurrence; Rifampin; Sex Factors | 1988 |
[Recurrent polychondritis (report of a case)].
Topics: Atrophy; Basal Ganglia; Calcinosis; Cartilage Diseases; Conjunctiva; Dapsone; Ear, External; Female; | 1987 |
Contribution of relapses to total infection sources of leprosy in Guadeloupe.
Topics: Adult; Child; Dapsone; Female; Humans; Leprosy; Male; Recurrence; West Indies | 1987 |
Relapse rates in lepromatous leprosy according to treatment regularity.
Topics: Dapsone; Humans; Leprosy; Mycobacterium leprae; Recurrence; Skin; Time Factors | 1986 |
Combined chemotherapy of multibacillary leprosy of 6 months' duration.
Topics: Adolescent; Adult; Child; Child, Preschool; Clofazimine; Dapsone; Drug Therapy, Combination; Female; | 1986 |
Preliminary results of treatment of leprosy patients in The Netherlands with daily rifampicin, dapsone and clofazimine.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprosy; Netherlands; Recurrence; Rifampin | 1986 |
First assessment of the Malta Leprosy Eradication Project.
Topics: Dapsone; Drug Combinations; Drug Therapy, Combination; Evaluation Studies as Topic; Follow-Up Studie | 1986 |
Long-term follow-up of dermatitis herpetiformis in children.
Topics: Child; Child, Preschool; Combined Modality Therapy; Dapsone; Dermatitis Herpetiformis; Female; Follo | 1986 |
The rate of relapse in lepromatous leprosy following completion of twenty years of supervised sulphone therapy.
Topics: Dapsone; Female; Humans; Leprosy; Male; Recurrence; Sulfones | 1986 |
The Kellersberger memorial lecture, 1984. Chemotherapy of leprosy--a tool for leprosy control.
Topics: Dapsone; Drug Therapy, Combination; Ethiopia; Humans; Leprostatic Agents; Leprosy; Recurrence | 1985 |
Risk of paucibacillary leprosy patients released from control relapsing with multibacillary leprosy.
Topics: Dapsone; Humans; Lepromin; Leprosy; Recurrence; Risk | 1985 |
[Palindromic rheumatism: efficacy of dapsone].
Topics: Arthritis; Dapsone; Humans; Male; Middle Aged; Recurrence | 1985 |
Acantholytic herpetiform dermatitis.
Topics: Acantholysis; Antibodies; Antibodies, Antinuclear; Biopsy; Blister; Dapsone; Dermatitis Herpetiformi | 1973 |
Quinine infusion for recrudescences of falciparum malaria in Vietnam: a controlled study.
Topics: Dapsone; Humans; Infusions, Parenteral; Malaria; Plasmodium falciparum; Pyrimethamine; Quinine; Recu | 1972 |
Recrudescent falciparum malaria in Vietnam.
Topics: Adult; Black People; Dapsone; Fever; Follow-Up Studies; Humans; Malaria; Male; Military Medicine; Pl | 1973 |
Chemoprophylaxis of malaria for travelers.
Topics: Africa; Antimalarials; Asia; Central America; Chloroquine; Dapsone; Drug Resistance, Microbial; Drug | 1974 |
Hormonal factors in dermatitis herpetiformis. Report of two cases.
Topics: Adolescent; Adult; Contraceptives, Oral; Dapsone; Dermatitis Herpetiformis; Estrogens; Female; Human | 1972 |
Mycetoma pedis, a report of two cases.
Topics: Chloramphenicol; Dapsone; Ethambutol; Foot Dermatoses; Humans; Male; Middle Aged; Mycetoma; Radiogra | 1973 |
Metabolic disposition of dapsone in patients with dapsone-resistant leprosy.
Topics: Acylation; Adult; Aged; Dapsone; Drug Resistance, Microbial; Female; Humans; Leprosy; Male; Middle A | 1974 |